LatestFDA Detects Cyclospora at Mexican Farm Linked to Largest U.S. Outbreak
Health

New Weight-Loss Injection CBL-514 Selectively Targets Fat Cells

New Weight-Loss Injection CBL-514 Selectively Targets Fat Cells
DiabetesObesity
Summary

A promising new drug called CBL-514 will be presented at the European Association for the Study of Diabetes annual meeting in Milan. The injection works by selectively triggering apoptosis (programmed cell death) in fat cells, reducing both subcutaneous and visceral fat. According to Dr. W. Timothy Garvey of the University of Alabama at Birmingham, CBL-514 also helps prevent weight regain after patients discontinue GLP-1 receptor agonist medications. This development offers a potential new strategy for managing obesity and maintaining long-term weight loss.

Medical Xpress

Originally published on

Medical Xpress

Read full article(opens in new tab)

Fetched: October 3, 2026 at 10:01 AM

Related News

More news you might be interested in

View all
FDA Detects Cyclospora at Mexican Farm Linked to Largest U.S. Outbreak
Health

FDA Detects Cyclospora at Mexican Farm Linked to Largest U.S. Outbreak

The FDA confirmed detection of cyclospora parasites at a Mexican farm responsible for the largest foodborne illness outbreak of this pathogen in U.S. history. The contamination was traced to lettuce products distributed throughout the country. Cyclospora causes severe gastrointestinal illness characterized by diarrhea, nausea, and abdominal cramps that can last weeks if untreated. This finding underscores the importance of food safety protocols in agricultural production and highlights risks associated with imported produce. Health authorities recommend thoroughly washing all leafy greens and following FDA guidelines on produce safety.

1 hour ago
Medical Xpress
Florida's dengue outbreak is now the largest in the continental US in decades
Health

Florida's dengue outbreak is now the largest in the continental US in decades

Florida is currently experiencing the largest dengue outbreak in several decades across the continental United States. The dengue virus, transmitted by Aedes mosquitoes, causes fever, joint pain, and rash in infected individuals. This significant outbreak underscores the growing public health threat of vector-borne diseases in the US and highlights the importance of mosquito control measures and personal protection strategies. Health authorities recommend residents use insect repellent, wear protective clothing, and eliminate standing water where mosquitoes breed to reduce transmission risk.

2 hours ago
Medical Xpress
GLP-1 Receptor Agonists Increase Risk of Pulmonary Aspiration During Anesthesia
Health
DiabetesObesity

GLP-1 Receptor Agonists Increase Risk of Pulmonary Aspiration During Anesthesia

A new UK study reveals that patients taking GLP-1 receptor agonists (GLP-1 RAs)—medications commonly used to treat diabetes and obesity—face an increased risk of pulmonary aspiration and regurgitation during anesthesia. The research, presented at the Association of Anaesthetists annual meeting, found that 2.9% of anesthesia patients were using these medications. Pulmonary aspiration occurs when stomach contents enter the lungs during surgery, potentially causing serious complications. Anesthesiologists recommend that patients inform their surgical teams about GLP-1 RA use beforehand to ensure appropriate safety precautions are implemented during procedures.

8 hours ago
Medical Xpress
A heart valve that grows up with the patient wins FDA approval
Health
Heart Disease

A heart valve that grows up with the patient wins FDA approval

The FDA has approved a revolutionary replacement heart valve designed to grow with pediatric patients, potentially reducing the number of open-heart surgeries children require throughout their lives. Traditional replacement valves do not expand as children grow, necessitating multiple surgical interventions as patients age. This innovative technology represents a significant advancement for children born with congenital heart defects, offering improved quality of life and fewer invasive procedures. The approval marks an important milestone in pediatric cardiology, addressing a long-standing clinical challenge in managing heart disease in growing patients.

12 hours ago
Medical Xpress